)
)
SAB Biotherapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from SAB Biotherapeutics Inc
Access all reports
SAB Biotherapeutics Inc. is a biotechnology company focused on developing immunotherapies using its proprietary DiversitAb platform. The company specializes in producing targeted, fully human polyclonal antibodies for infectious diseases, autoimmune disorders, and other conditions. SAB Biotherapeutics leverages genetically engineered cattle to generate scalable and high-potency antibody treatments. The company is headquartered in Sioux Falls, South Dakota, and its shares are listed on the NASDAQ.
Key slides for SAB Biotherapeutics Inc
Corporate Presentation
SAB Biotherapeutics Inc
Study Update
SAB Biotherapeutics Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
SABS
Country
🇺🇸 United States